Search
Inhibikase Therapeutics Inc
IKTAdd to Watchlist
2.330USD
+0.160+7.37%
Close 07-23 16:00（ET）Quotes delayed by 15 min
307.64MMarket Cap
LossP/E TTM
Inhibikase Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-23The current valuation score of Inhibikase Therapeutics Inc is 6.52, ranking 320 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.38, which is -184.50% below the recent high of 4.54 and -869.43% above the recent low of -52.14.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.